Clay Thorp Clearside Biomedical, Inc. (CLSD) insider trading activity

CLSD Quotes by TradingView

Clay Thorp is of Clearside Biomedical, Inc.. Currently has a direct ownership of 176,141 shares of CLSD, which is worth approximately $162,049. The most recent transaction as insider was on Feb 24, 2025, when has been sold 15,000 shares (Common Stock) at a price of $0.92 per share, resulting in proceeds of $13,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 176K
334.68% 3M change
334.68% 12M change
Total Value Held $162,049

Clay Thorp Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2025
BUY
Open market or private purchase
$13,800 $0.92 p/Share
15,000 Added 7.85%
176,141 Common Stock
Sep 25 2023
BUY
Open market or private purchase
$8,600 $0.86 p/Share
10,000 Added 19.79%
40,522 Common Stock
Dec 21 2022
BUY
Open market or private purchase
$14,280 $1.02 p/Share
14,000 Added 31.45%
30,522 Common Stock
Dec 15 2022
BUY
Other acquisition or disposition
-
8,522 Added 34.03%
16,522 Common Stock

Also insider at

PHAS
PhaseBio Pharmaceuticals Inc Healthcare
Director
VIGL
Vigil Neuroscience, Inc. Healthcare
Director
CT

Clay Thorp

Malvern, PA

Track Institutional and Insider Activities on CLSD

Follow Clearside Biomedical, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLSD shares.

Notify only if

Insider Trading

Get notified when an Clearside Biomedical, Inc. insider buys or sells CLSD shares.

Notify only if

News

Receive news related to Clearside Biomedical, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLSD